PRESS RELEASE published on 02/23/2023 at 20:00, 3 years 1 month ago Abivax annonce la mise à disposition d’un prospectus dans le cadre de son augmentation de capital
PRESS RELEASE published on 02/22/2023 at 18:05, 3 years 1 month ago Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
PRESS RELEASE published on 02/22/2023 at 18:05, 3 years 1 month ago Abivax annonce le succès d’un financement cross-over sursouscrit de 130 millions d’euros au prix du marché, par des investisseurs américains et européens de premier plan
PRESS RELEASE published on 02/17/2023 at 08:00, 3 years 2 months ago Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
PRESS RELEASE published on 02/17/2023 at 08:00, 3 years 2 months ago Abivax: Le Dr. Sheldon Sloan, M.D., est nommé Directeur Médical d’Abivax
PRESS RELEASE published on 02/14/2023 at 18:00, 3 years 2 months ago Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
PRESS RELEASE published on 02/14/2023 at 18:00, 3 years 2 months ago Abivax présentera lors du 18ème Congrès de l’ECCO des données issues d’échantillons sanguins et de biopsies rectales de patients atteints de RCH et traités avec obefazimod
PRESS RELEASE published on 01/31/2023 at 18:00, 3 years 2 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 01/31/2023 at 18:00, 3 years 2 months ago ABIVAX: AVIS AUX PORTEURS D’OBLIGATIONS CONVERTIBLES/ECHANGEABLES EN ACTIONS NOUVELLES ET/OU EXISTANTES (OCEANES) D’UN MONTANT NOMINAL DE 24 999 975,99 EUROS
PRESS RELEASE published on 01/30/2023 at 18:00, 3 years 2 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
Published on 04/21/2026 at 10:00, 1 hour 25 minutes ago Silver Range Advances the Drum Project in Utah
Published on 04/21/2026 at 09:05, 2 hours 20 minutes ago Battery X Metals Files International PCT Patent Application for Lithium-Ion Battery Rebalancing Technology, Providing a Pathway to Pursue Patent Protection in 150+ Countries for Technology Validated by a Leading Scientific Institution to Recover ~99% Capa
Published on 04/21/2026 at 05:30, 5 hours 55 minutes ago Battery X Metals Provides Update on Critical Battery Metals Exploration Initiatives and Portfolio Optimization Strategy
Published on 04/21/2026 at 01:05, 10 hours 20 minutes ago Boron One Holdings Inc. Announces Closing of Financing
Published on 04/21/2026 at 00:00, 11 hours 25 minutes ago LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
Published on 04/21/2026 at 11:05, 20 minutes ago Hisense Ignites the Countdown to the FIFA World Cup 2026™, Showcasing Next-Generation Home Entertainment and Smart Living
Published on 04/21/2026 at 11:00, 25 minutes ago hep global Develops 4.1 MWp Solar Park with Battery Storage in Biessenhofen
Published on 04/21/2026 at 11:00, 25 minutes ago Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective Target Space for Next-Generation ADCs at AACR 2026
Published on 04/21/2026 at 10:30, 55 minutes ago Invitation to the 19th International Investment Forum (IIF) on May 20, 2026 – Digital Focus on Global Growth Stocks
Published on 04/21/2026 at 10:05, 1 hour 20 minutes ago BrightCharger and Endrich sign licensing agreement to expand BrightZero® charging control to new components and products
Published on 04/21/2026 at 07:00, 4 hours 25 minutes ago Thales reports its order intake and sales for the first quarter of 2026
Published on 04/21/2026 at 07:00, 4 hours 25 minutes ago Thales publie ses prises de commandes et son chiffre d'affaires du premier trimestre 2026
Published on 04/21/2026 at 06:59, 4 hours 26 minutes ago OPmobility - Chiffre d'affaires du 1er trimestre 2026
Published on 04/20/2026 at 20:44, 14 hours 41 minutes ago ENGIE - Implementation of share buyback programme
